C4 Therapeutics (CCCC) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to -$26.4 million.
- C4 Therapeutics' Other Gross PP&E Adjustments rose 4005.63% to -$26.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.4 million, marking a year-over-year increase of 4005.63%. This contributed to the annual value of -$53.5 million for FY2024, which is 801.93% up from last year.
- Per C4 Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$26.4 million for Q3 2025, which was up 4005.63% from -$38.7 million recorded in Q2 2025.
- C4 Therapeutics' 5-year Other Gross PP&E Adjustments high stood at -$3.1 million for Q3 2021, and its period low was -$65.6 million during Q1 2022.
- In the last 5 years, C4 Therapeutics' Other Gross PP&E Adjustments had a median value of -$47.5 million in 2024 and averaged -$41.5 million.
- As far as peak fluctuations go, C4 Therapeutics' Other Gross PP&E Adjustments soared by 5118.86% in 2021, and later plummeted by 173525.97% in 2022.
- Over the past 5 years, C4 Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$25.6 million in 2021, then tumbled by 137.88% to -$60.9 million in 2022, then rose by 4.54% to -$58.1 million in 2023, then increased by 8.02% to -$53.5 million in 2024, then surged by 50.57% to -$26.4 million in 2025.
- Its last three reported values are -$26.4 million in Q3 2025, -$38.7 million for Q2 2025, and -$40.8 million during Q1 2025.